Human Retroviruses and Anti-Viral Therapies

  • R. C. Gallo
  • M. S. ReitzJr.
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 143)


At least four types of human retroviruses are currently identified. They are causally involved in several different kinds of diseases in humans, including leukemia and lymphoma immunodeficiency diseases and neurologic and central nervous system diseases. Their identification has led to the ability to easily detect them and to a basic understanding of their life cycle. This knowledge makes possible various strategies for prevention and treatment of diseases due to infection by these viruses.


Human Immunodeficiency Virus Type Central Nervous System Disease Hairy Cell Leukemia Viral mRNA Tropical Spastic Paraparesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B.J. Poiesz, F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Minna, and R.C. Gallo, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci USA 77:7415 (1980).PubMedCrossRefGoogle Scholar
  2. 2.
    V.S. Kalyanaraman, M.G. Sarngadharan, M. Robert-Guroff, I. Miyoshi, D. Blayney, D. Golde, and R.C. Gallo, A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia, Science 218:571 (1982).PubMedCrossRefGoogle Scholar
  3. 3.
    R.C. Gallo, S.Z. Salahuddin, M. Popovic, G.M. Shearer, M. Kaplan, B.F. Haynes, T.J. Palker, R. Redfield, J. Oleste, B. Safai, G. White, P. Foster, and P.D. Markham, Frequent detection and isolation of cyto-pathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science 224:500 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    F. Barré-Sinoussi, J.C. Chermann, F. Rey, M.T. Nugeybe, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Brun-Vezinet, C. Rou-zioux, W. Rozenbaum, and L. Montagnier, Isolation of a T-lymphotropic retrovirus from a patient as risk of acquired immune deficiency syndrome (AIDS), Science 220:868 (1983).PubMedCrossRefGoogle Scholar
  5. 5.
    P.J. Kanki, J. Alroy, and M. Essex, Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys, Science 230:951 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    F. Clavel, D. Guetard, F. Brun-Vezinet, S. Chamaret, M.A. Rey, M.O. Santos-Ferreira, A.G. Laurent, C. Dauguet, C. Katlama, C. Rouzioux, D. Klatzmann, S.L. Champalimand, and L. Montagnier, Isolation of a new human retrovirus from West African patients with AIDS, Science 233:343 (1986).PubMedCrossRefGoogle Scholar
  7. 7.
    P.J. Kanki, F. Barin, S. M’Boup, J.S. Allan, J.L. Romet-Lemonne, R. Markink, M.F. McLane, T.H. Lee, B. Arbeille, and M. Essex, New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-III), Science 232:238 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    F. Wong-Staal and R.C. Gallo, Human T-lymphotropic retroviruses, Nature 317:395 (1985).PubMedCrossRefGoogle Scholar
  9. 9.
    H. Mitsuya and S. Broder, Strategies for antiviral therapy in AIDS, Nature 325:773 (1987).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • R. C. Gallo
    • 1
  • M. S. ReitzJr.
    • 1
  1. 1.Laboratory of Tumor Cell Biology, National Cancer InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations